Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa

• Autores: Kanan, Yogita; Khan, Mahmood; Lorenc, Valeria Erika; Long, Da; Chadha, Rishi; Sciamanna, Jason; Green, Ken; Campochiaro, Peter A.
• Año de publicación: 2019
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: ELECTRORETINOGRAM; NITROSATIVE DAMAGE; RETINAL DEGENERATION
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

Metipranolol is a b-adrenergic receptor antagonist that is given orally for the treatment of hypertension and also applied topically to the cornea for treating glaucoma. It also inhibits nitrosative stress which has previously been shown to be the cause of cone photoreceptor death in retinitis pigmentosa. In this study, we tested the hypothesis that metipranolol protects photoreceptor structure and function in the mouse model rd10. At P35, compared with vehicle-treated rd10 mice in which rod degeneration was nearly complete, rd10 mice given daily subcutaneous injections of 40 mg/kg of metipranolol had reduction in markers of nitrosative stress, fewer TUNELpositive cells, increased outer nuclear layer thickness, and substantially more staining for rhodopsin. This was accompanied by significantly higher mean scotopic and photopic electroretinogram b-wave amplitudes indicating improved photoreceptor function. At P50, metipranolol-treated rd10 mice had decreased 3-nitrotyrosine staining in the retina, increased immunostaining for cone arrestin, a marker for cone photoreceptors, and significantly higher scotopic and photopic b-wave amplitudes at the highest stimulus intensity compared with vehicle-treated mice. At P65, cone density was significantly higher in metipranolol-treated versus vehicle-injected rd10 mice. Metipranolol applied as eye drops promoted cone photoreceptor function in retinas of rd10 mice greater than subcutaneously injected metipranolol. The reduced nitrosative damage and rescue of functional loss of photoreceptors in rd10 mice suggests that metipranolol, a drug with established ocular safety and tolerability, may have potential for treating patients with retinitis pigmentosa.
Fil: Kanan, Yogita. University Johns Hopkins; Estados Unidos
Fil: Khan, Mahmood. University Johns Hopkins; Estados Unidos
Fil: Lorenc, Valeria Erika. University Johns Hopkins; Estados Unidos. Universidad Austral. Facultad de Ciencias Biomédicas. Instituto de Investigaciones en Medicina Traslacional. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones en Medicina Traslacional; Argentina
Fil: Long, Da. University Johns Hopkins; Estados Unidos
Fil: Chadha, Rishi. University Johns Hopkins; Estados Unidos
Fil: Sciamanna, Jason. University Johns Hopkins; Estados Unidos
Fil: Green, Ken. University Johns Hopkins; Estados Unidos
Fil: Campochiaro, Peter A.. University Johns Hopkins; Estados Unidos